Clinical Trials Browser

Interventional × Abdominal Neoplasms × Doxorubicin × Clear all

NCT03111069 2018-07-20

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Phase 1 Withdrawn

Abdominal Neoplasms, Rhabdomyosarcoma